2025. Evaluation Of The Protective Role Of Empagliflozin In Inflammation-Triggered Kidney Disease In Preclinical Settings. International Journal of Environmental Sciences. (Sep. 2025), 3552–3558. DOI:https://doi.org/10.64252/pbnwgb08.